INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,117 | -42.3% | 2,344 | -25.6% | 0.00% | -25.0% |
Q2 2023 | $128,456 | +2.9% | 3,150 | -6.0% | 0.00% | 0.0% |
Q1 2023 | $124,854 | +6.7% | 3,350 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $117,055 | -36.0% | 3,355 | +2.4% | 0.00% | -42.9% |
Q3 2022 | $183,000 | +1.1% | 3,275 | -6.7% | 0.01% | +16.7% |
Q2 2022 | $181,000 | +16.8% | 3,511 | +164.6% | 0.01% | +20.0% |
Q4 2021 | $155,000 | -4.9% | 1,327 | +8.7% | 0.01% | 0.0% |
Q3 2021 | $163,000 | +1.9% | 1,221 | +22.5% | 0.01% | -44.4% |
Q2 2021 | $160,000 | +97.5% | 997 | -2.2% | 0.01% | +80.0% |
Q1 2021 | $81,000 | – | 1,019 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |